Allt inom Q2
Nanexa publishes interim report for January – June 2023
Strong preclinical progress with NEX-22, positive Phase 1 data with NEX-20 and several partner projects in preclinical evaluation
Nanexa publishes interim report for January – June 2022
The pilot plant inaugurated and GMP certified, patent approved in Europe and product projects approaching clinical phase